MeCP2 could specifically bind to the CD147 promoter, and the binding was reduced in NSCLC compared with normal lung tissues; this trend was consistent with the results obtained for KLF6 and DNMT3A (Fig. 2A). This evidence concerns the gene MECP2 and non-small cell lung carcinoma.